These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 17049998)

  • 21. Venlafaxine efficacy and tolerability in the treatment of post-stroke depression.
    Kucukalić A; Bravo-Mehmedbasić A; Kulenović AD; Suljić-Mehmedika E
    Psychiatr Danub; 2007 Jun; 19(1-2):56-60. PubMed ID: 17603417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Action monitoring and depressive symptom reduction in major depressive disorder.
    Schrijvers D; De Bruijn ER; Maas YJ; Vancoillie P; Hulstijn W; Sabbe BG
    Int J Psychophysiol; 2009 Mar; 71(3):218-24. PubMed ID: 18926863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term plasticity of visually evoked potentials in humans is altered in major depression.
    Normann C; Schmitz D; Fürmaier A; Döing C; Bach M
    Biol Psychiatry; 2007 Sep; 62(5):373-80. PubMed ID: 17240361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrence of major depressive disorder is predicted by inhibited startle magnitude while recovered.
    O'Brien-Simpson L; Di Parsia P; Simmons JG; Allen NB
    J Affect Disord; 2009 Jan; 112(1-3):243-9. PubMed ID: 18495249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting.
    Bukh JD; Jørgensen MB; Dam H; Plenge P
    Nord J Psychiatry; 2009; 63(4):347-51. PubMed ID: 19347769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Desvenlafaxine: another "me too" drug?
    Sopko MA; Ehret MJ; Grgas M
    Ann Pharmacother; 2008 Oct; 42(10):1439-46. PubMed ID: 18698015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of late-life depression after 3 years of sequential treatment.
    Kok RM; Nolen WA; Heeren TJ
    Acta Psychiatr Scand; 2009 Apr; 119(4):274-81. PubMed ID: 19053970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression.
    Janssen J; Hulshoff Pol HE; Schnack HG; Kok RM; Lampe IK; de Leeuw FE; Kahn RS; Heeren TJ
    Int J Geriatr Psychiatry; 2007 May; 22(5):468-74. PubMed ID: 17357181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interhemispheric cerebral asymmetry detected by VEPS in diabetic patients with recognized depression.
    Janocha A; Pilecki W; Bolanowski M; Małyszczak K; Salomon E; Laszki-Szczachor K; Kałka D; Sebzda T; Sobieszczańska M
    Neuro Endocrinol Lett; 2009 Mar; 30(1):119-24. PubMed ID: 19300390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the Depression and Somatic Symptoms Scale by comparison with the Short Form 36 scale among psychiatric outpatients with major depressive disorder.
    Hung CI; Wang SJ; Liu CY
    Depress Anxiety; 2009; 26(6):583-91. PubMed ID: 19242983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mid-term effects of serial sleep deprivation therapy implemented in cognitive-behavioral treatment on the neuroendocrine response to clomipramine in patients with major depression.
    Kundermann B; Strate P; Hemmeter-Spernal J; Huber MT; Krieg JC; Lautenbacher S
    J Psychiatr Res; 2009 Apr; 43(7):711-20. PubMed ID: 18930473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No differences between drug naive and drug experienced unipolar depressed patients in terms of neurobiological testing: a cross sectional study.
    Fountoulakis KN; Gonda X; Andreoulakis E; Fokas K; Iacovides A
    J Psychiatr Res; 2013 Dec; 47(12):1984-90. PubMed ID: 24074518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapy for cataplexy.
    Houghton WC; Scammell TE; Thorpy M
    Sleep Med Rev; 2004 Oct; 8(5):355-66. PubMed ID: 15336236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do depressive patients with family history of dementia constitute a separate group? A case report study.
    Fountoulakis KN; Fotiou F; Iacovides A; Kaprinis G
    Int J Psychiatry Clin Pract; 2000; 4(3):215-22. PubMed ID: 24927456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroimaging profiles and the differential therapies of depression.
    Thase ME
    Arch Gen Psychiatry; 2001 Jul; 58(7):651-3. PubMed ID: 11448371
    [No Abstract]   [Full Text] [Related]  

  • 36. Pattern-reversed visual evoked potentials in subtypes of major depression.
    Fotiou F; Fountoulakis KN; Iacovides A; Kaprinis G
    Psychiatry Res; 2003 Jun; 118(3):259-71. PubMed ID: 12834820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venlafaxine associated urinary symptoms.
    Alexander J; McKenny B; Chaudhary J
    Aust N Z J Psychiatry; 2010 Dec; 44(12):1145. PubMed ID: 21070112
    [No Abstract]   [Full Text] [Related]  

  • 38. Relationship among Dexamethasone Suppression Test, personality disorders and stressful life events in clinical subtypes of major depression: An exploratory study.
    Fountoulakis K; Iacovides A; Fotiou F; Karamouzis M; Demetriadou A; Kaprinis G
    Ann Gen Hosp Psychiatry; 2004 Dec; 3(1):15. PubMed ID: 15598349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is it possible to predict the long-term response to venlafaxine with the use of biological markers and psychophysiological methods?
    Fountoulakis KN; Iacovides A; Karamouzis M; Gerasimou G; Grammatikos P; Fotiou F; Kaprinis G
    J Affect Disord; 2007 Apr; 99(1-3):155-63. PubMed ID: 17049998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurobiological and psychological correlates of suicidal attempts and thoughts of death in patients with major depression.
    Fountoulakis KN; Iacovides A; Fotiou F; Nimatoudis J; Bascialla F; Ioannidou C; Kaprinis G; Bech P
    Neuropsychobiology; 2004; 49(1):42-52. PubMed ID: 14730200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.